Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
32.70
+1.27 (4.04%)
Aug 15, 2025, 4:00 PM - Market closed
Vaxcyte Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$136.50
Upside
+317.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 22, 2025 |
| Needham | Needham | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +175.23% | Apr 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $138 → $100 | Strong Buy | Maintains | $138 → $100 | +205.81% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $157 → $137 | Strong Buy | Maintains | $157 → $137 | +318.96% | Apr 1, 2025 |
| Needham | Needham | Strong Buy Maintains $140 → $90 | Strong Buy | Maintains | $140 → $90 | +175.23% | Apr 1, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +389.30% | Mar 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +389.30% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +328.13% | Feb 26, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +389.30% | Feb 24, 2025 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | -57.19% | Feb 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +312.84% | Dec 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +328.13% | Nov 6, 2024 |
| Mizuho | Mizuho | Buy Maintains $113 → $163 | Buy | Maintains | $113 → $163 | +398.47% | Sep 10, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $101 → $140 | Strong Buy | Maintains | $101 → $140 | +328.13% | Sep 4, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $106 → $153 | Buy | Maintains | $106 → $153 | +367.89% | Sep 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.